1. Home
  2. IVVD vs CCAQ Comparison

IVVD vs CCAQ Comparison

Compare IVVD & CCAQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Invivyd Inc.

IVVD

Invivyd Inc.

N/A

Current Price

$0.46

Market Cap

212.6M

Sector

Health Care

ML Signal

N/A

CCAQ

Collective Acquisition Corp. Class A Ordinary Shares

N/A

Current Price

$10.69

Market Cap

213.4M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
IVVD
CCAQ
Founded
2020
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
212.6M
213.4M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
IVVD
CCAQ
Price
$0.46
$10.69
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $10.00
N/A
AVG Volume (30 Days)
★ 3.4M
25.2K
Earning Date
11-16-2026
08-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 79.02
N/A
EPS
N/A
★ N/A
Revenue
★ $53,426,000.00
N/A
Revenue This Year
$12.92
N/A
Revenue Next Year
$44.18
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 110.47
N/A
52 Week Low
$0.49
$10.43
52 Week High
$3.01
$10.88

Technical Indicators

Market Signals
Indicator
IVVD
CCAQ
Relative Strength Index (RSI) 30.94 62.29
Support Level N/A $10.46
Resistance Level $0.66 $10.70
Average True Range (ATR) 0.05 0.09
MACD -0.01 0.01
Stochastic Oscillator 5.08 54.32

Price Performance

Historical Comparison
IVVD
CCAQ

About IVVD Invivyd Inc.

Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.

About CCAQ Collective Acquisition Corp. Class A Ordinary Shares

Collective Acquisition Corp is a blank check company.

Share on Social Networks: